Indicators

Markets:

News

Latest News about Vertex Pharmaceuticals Inc

Recent news which mentions Vertex Pharmaceuticals Inc

Trump's pharmaceutical tariffs could affect some drugmakers more than others

July 29, 2025

Healthy Returns: Medicaid cuts in Trump’s megabill may affect some drugmakers more than others

July 08, 2025

Cramer's week ahead: Earnings from Disney, Palantir and Uber

May 02, 2025

Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks

April 01, 2025

Jim Cramer says 'the market may be far healthier than we think.' Here's why

March 27, 2025

Once high-flying Bluebird Bio sells itself to private equity after tough times for the gene therapy maker

February 21, 2025

High-cost sickle cell gene therapies push insurers and Medicaid programs to find new payment models

February 18, 2025

FDA approves Vertex’s non-opioid painkiller, first new kind of pain medicine in decades

January 30, 2025

Cramer's Lightning Round: 'I would be a seller of QuantumScape'

January 08, 2025

Cramer's Lightning Round: Vertex Pharmaceuticals is a buy

October 30, 2024

Healthy Returns: Pfizer pulls sickle cell disease drug from markets – here’s why it matters

October 01, 2024

Cramer's Lightning Round: Builders FirstSource 'can go higher'

August 28, 2024

Cramer's Lighting Round: Vertex Pharmaceuticals is 'terrific'

April 08, 2024

New sickle cell gene therapies are a breakthrough, but solving how to pay their high prices is a struggle

February 23, 2024

Vertex non-opioid painkiller shows positive results in critical late-stage trial on acute pain

January 30, 2024

Vertex shares pop after non-opioid painkiller posts positive mid-stage trial results

December 13, 2023

U.S. approves first gene-editing treatment, Casgevy, for sickle cell disease

December 08, 2023

U.S. poised to approve first gene-editing treatment in breakthrough for sickle cell patients

December 07, 2023

Here are 16 stocks Jim Cramer is watching, including Microsoft, Chevron, Southwest

October 30, 2023

20 stocks I'm watching in the market, including Emerson, DoorDash, Royal Caribbean

October 09, 2023

Cramer says Vertex has a drug that may address the 'largest market opportunity in the world'

October 09, 2023

Cramer's Lightning Round: Vertex is 'excellent'

October 05, 2023

Stocks making the biggest moves after hours: Arista Networks, MGM Resorts, Stryker and more

May 01, 2023

Stocks making the biggest moves midday: Walgreens, Coinbase, Duolingo, Ralph Lauren and more

November 11, 2022

Cramer's lightning round: Stay with Vertex Pharmaceuticals

October 27, 2022

Stocks making the biggest moves after hours: Amazon, Apple, Pinterest, Intel and more

October 27, 2022

Jim Cramer says investors should eye these three tech names in the Nasdaq 100

July 05, 2022

Cramer's lightning round: I'm sticking with Marvell Technology

June 22, 2022

Stocks making the biggest moves midday: Global Payments, Moderna, Activision Blizzard and more

May 02, 2022

Some of the first quarter’s biggest losers could be the biggest steals, Jim Cramer says

April 04, 2022

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.